Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Abstract Text:

Nobutomo Yamamoto,Tatsuro Oda,Toshiya Inada,Nobutomo Yamamoto,Tatsuro Oda,Toshiya Inada,Nobutomo Yamamoto,Tatsuro Oda,Toshiya Inada,

Reported herein is a case of methamphetamine psychosis in which tardive dystonia was treated successfully with clonazepam. The patient was a 69-year-old man who had taken methamphetamine habitually for approximately 40 years. Auditory hallucinations had developed 25 years previously, for which haloperidol had been prescribed. Tardive dystonia had developed in December 2005. Haloperidol was withdrawn and risperidone or olanzapine alone had been administered, but neither had improved the dystonic posture. However, when clonazepam was added, a gradual improvement in the dystonic posture became evident. Tardive dystonia is currently treated on a trial-and-error basis. Accumulation of further cases similar to the present one is very important for establishing an effective treatment.

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Publishing Authors By Initials

N Yamamoto,T Oda,T Inada,N Yamamoto,T Oda,T Inada,N Yamamoto,T Oda,T Inada,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Psychiatry and clinical neurosciences

VOLUME: 61

Page Numbers: 691-4

Journal Abbreviation: Psychiatry Clin. Neurosci.

ISSN: 1323-1316

DAY: 17

MONTH: Dec

YEAR: 2007

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9513551

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.

AFFILIATION: Department of Psychiatry, Shimofusa Psychiatric Medical Center, Chiba City, Chiba, Japan.

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Psychiatry Clin Neurosci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam Related Publications

• An experimental study on home health care support information system construction.
• D, L-aspartic acid beta-p-nitroanilide as a substrate for the assay of asparaginase.
• Dermoid cyst of the mediastinum communicating with a bronchus; report of two cases.
• Disruption of charge separation followed by that of the proton gradient in the mitochondrial membrane by CCCP.
• Isolation of apoptosis- and differentiation-inducing substances toward human promyelocytic leukemia HL-60 cells from leaves of Juniperus taxifolia.
• Matrix metalloproteinases and bone.
• Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
• Physicochemical properties and states of sulfhydryl groups of uricase from Candida utilis.
• Polyethylene glycol-modified pokeweed mitogen (PWM) as a potential non-immunogenic stimulator of lymphokine-activated killer cells.
• Proton therapy in Japan.
• Reactivity of peptide imino groups in proteins with tert-butyl hypochlorite in relation to secondary structure.
• Selective synthesis of 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine as a protein modifier.
• Sodium trichloroacetate as a denaturation reagent for proteins.
• Spectral change of rhodamine 6G caused by the energization of mitochondria, in relation to charge separation.
• Spectral changes of porcine trypsin induced by divalent cations.
• States of imino groups in pepsin measured by the reactivity with tertiary-butylhypochlorite.
• States of tyrosine residues in the molecules of insulin, lysozyme and catalase.
• States on imino groups in collagen as measured with a modifying reagent, tert-butyl hypochlorite.
• The degree of newly emerging mitral regurgitation during off-pump coronary artery bypass is predicted by preoperative left ventricular function.
• The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA).
• Three cases of schizophrenia for which olanzapine was effective after early acute phase.
• Three dimensional spot beam scanning method for proton conformation radiation therapy.
• Thrombin-catalyzed conversion of fibrinogen to fibrin.
• Tolerogenic capacity of poly(ethylene glycol) (PEG)--modified ovalbumins in relation to their immunoreactivity towards anti-ovalbumin antibody.
• Using problem-based learning for pandemic preparedness.
• [Absorbed dose measurement of photon beam with Farmer-type ionization chambers in Japanese dosimetry protocols]
• [Experimental study of ringed vascular graft in dogs (author's transl)]
• [Psychiatric and neurological side effects]
• [Risk management in cardiac anesthesia]
• [Thoracoscopic enucleation for sclerosing hemangioma of the lung--a case report]